TY - JOUR
T1 - The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma
AU - van Laarhoven, Hanneke W. M.
AU - Derks, Sarah
N1 - Publisher Copyright: © 2023 The Author(s)
PY - 2023/4/18
Y1 - 2023/4/18
N2 - In the ASTRUM-007 randomized double-blind phase III study, Song et al.1 showed that the combination of PD-1 inhibitors with first-line fluoropyrimidine and platinum-based chemotherapy improves outcomes in PD-L1-overexpressing esophageal squamous cell carcinomas.
AB - In the ASTRUM-007 randomized double-blind phase III study, Song et al.1 showed that the combination of PD-1 inhibitors with first-line fluoropyrimidine and platinum-based chemotherapy improves outcomes in PD-L1-overexpressing esophageal squamous cell carcinomas.
UR - http://www.scopus.com/inward/record.url?scp=85152979460&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.xcrm.2023.100990
DO - https://doi.org/10.1016/j.xcrm.2023.100990
M3 - Comment/Letter to the editor
C2 - 37075702
SN - 2666-3791
VL - 4
JO - Cell Reports Medicine
JF - Cell Reports Medicine
IS - 4
M1 - 100990
ER -